News
Media
Conference
Publication
CME/CE
Partners
Resources
Contribute
Subscribe
Clinical Forum Insights

DOTS Trial Insights: Evaluating an Antibiotic's Role in Complicated Staphylococcus aureus Bacteremia

1 expert is featured in this series.

EP. 1: Two-Dose Antibiotic Regimen Offers Safer Alternative to Prolonged IV Therapy in Complicated Staph Aureus Infections

ByNicholas Turner, MD,

September 30th 2025

1 expert is featured in this series.

EP. 2: Reducing Both Treatment Burden, Risks Associated With Prolonged IV Therapy

ByNicholas Turner, MD,

October 7th 2025

1 expert is featured in this series.

EP. 3: DOOR Analysis Shows Antibiotic Matches Standard Therapy in Effectiveness

ByNicholas Turner, MD,

October 14th 2025

1 expert is featured in this series.

EP. 4: Treatment Shows Comparable Safety to Standard Therapy, Offering Key Benefits for Select Patient Populations

ByNicholas Turner, MD,

October 21st 2025

1 expert is featured in this series.

EP. 5: Consolidation Therapy Shows Promise but Highlights Study Limitations

ByNicholas Turner, MD,

October 28th 2025

1 expert is featured in this series.

EP. 6: Cost, Dosing Strategies, and Clinical Boundaries in Complicated Staph aureus

ByNicholas Turner, MD,

November 4th 2025

Trending on Contagion Live

Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus

Measles Update: February 6, 2026

PASTEUR Act Reintroduced in Congress

Antibiotics Deconstructed: IV Fosfomycin

HIV Spending for Fiscal Year 2026: The Latest Update